Anne Borgman, M.D.

Anne Borgman, M.D.

Chief Medical OfficeratSutro Biopharma· In the 2023 proxy

Pay in FY2023Sutro Biopharma stock -46.9% the same year

Anne Borgman, M.D. was paid $2.3M in FY2023 (Dec). Sutro Biopharma stock fell 46.9% that year.

Pay$100 in the stock at the end of FY22 → $53
Pay is from the Summary Compensation Table of each Sutro Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sutro BiopharmaPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?